Daily Stock Analysis, BDX, Becton Dickinson and Co, priceseries

Becton Dickinson and Co. Daily Stock Analysis
Stock Information
Open
183.67
Close
183.87
High
185.09
Low
183.42
Previous Close
183.71
Daily Price Gain
0.16
YTD High
185.70
YTD High Date
Mar 10, 2017
YTD Low
160.86
YTD Low Date
Jan 3, 2017
YTD Price Change
19.38
YTD Gain
11.78%
52 Week High
185.70
52 Week High Date
Mar 10, 2017
52 Week Low
145.90
52 Week Low Date
Mar 28, 2016
52 Week Price Change
37.21
52 Week Gain
25.37%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Oct 27. 2015
137.31
Nov 12. 2015
144.90
12 Trading Days
5.53%
Link
LONG
Feb 12. 2016
136.98
Mar 8. 2016
145.26
16 Trading Days
6.05%
Link
Company Information
Stock Symbol
BDX
Exchange
NYSE
Company URL
http://www.bd.com
Company Phone
2018476800
CEO
Vincent A. Forlenza
Headquarters
New Jersey
Business Address
ONE BECTON DR, FRANKLIN LAKES, NJ 07417-1880
Sector
Equity
Industry Category
Health Services
Industry Group
Medical Instruments & Supplies
CIK
0000010795
About

Becton, Dickinson and Company develops, manufactures, and sells medical devices, instrument systems, and reagents worldwide. The company's BD Medical segment offers syringes and pen needles for diabetes; needles, syringes, and intravenous cat...

Description

Becton, Dickinson and Company develops, manufactures, and sells medical devices, instrument systems, and reagents worldwide. The company's BD Medical segment offers syringes and pen needles for diabetes; needles, syringes, and intravenous catheters for medication delivery; prefilled IV flush syringes; regional anesthesia needles and trays; sharps disposal containers; closed-system transfer devices; skin antiseptic products; surgical and laproscopic instrumentations; generic prefilled injectables; intravenous medication safety and infusion therapy delivery, and automated medication dispensing and supply management systems; prefillable drug delivery systems; respiratory ventilation, and diagnostics equipment and consumables; and consumables for patient monitoring and anesthesia delivery. Its Life Sciences segment provides integrated systems for specimen collection; safety-engineered blood collection, automated blood culturing and tuberculosis culturing, and microorganism identification and drug susceptibility systems; molecular testing systems for infectious diseases and women's health; liquid-based cytology systems for cervical cancer screening; rapid diagnostic assays; microbiology laboratory automation, and plated media products; fluorescence-activated cell sorters and analyzers; monoclonal antibodies and kits for performing cell analysis; reagent systems for life science research; molecular indexing and next-generation sequencing sample preparation for genomics research; clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers; and cell culture media supplements for biopharmaceutical manufacturing. The company markets its products through independent distribution channels and sales representatives to healthcare institutions, life science researchers, clinical laboratories, pharmaceutical industry, and general public. Becton, Dickinson and Company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.